{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:52:37Z","timestamp":1777517557318,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ygyno.2004.09.028","type":"journal-article","created":{"date-parts":[[2004,12,13]],"date-time":"2004-12-13T22:57:31Z","timestamp":1102978651000},"page":"108-111","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study"],"prefix":"10.1016","volume":"96","author":[{"given":"Franco M.","family":"Muggia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Waggoner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Berek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley J.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Sorosky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2004.09.028_bib1","series-title":"Progress in oncology 2001","first-page":"168","article-title":"Chemoradiation for patients with cervical cancer","author":"Muggia","year":"2001"},{"key":"10.1016\/j.ygyno.2004.09.028_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients","volume":"12","author":"LeChevalier","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2004.09.028_bib3","first-page":"30","article-title":"Navelbine in advanced epithelial ovarian cancer: a study of the French Oncology Centers","volume":"16","author":"George","year":"1989","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2004.09.028_bib4","series-title":"Proceedings of a symposium. McLean, VA, April 28\u2013May 1, 1994","first-page":"1","article-title":"The current status of vinorelbine (Navelbine) in breast cancer","volume":"vol. 22 (Suppl. 5)","year":"1995"},{"issue":"3","key":"10.1016\/j.ygyno.2004.09.028_bib5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1200\/JCO.1998.16.3.1094","article-title":"Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix","volume":"16","author":"Morris","year":"1998","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2004.09.028_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ygyno.2003.10.045","article-title":"Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study","volume":"92","author":"Muggia","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2004.09.028_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2001.19.5.1275","article-title":"Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a gynecologic oncology group study","volume":"19","author":"Curtin","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2004.09.028_bib8","first-page":"1513","article-title":"Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a gynecologic oncology group study","volume":"68","author":"Thigpen","year":"1984","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.ygyno.2004.09.028_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/gyno.1993.1084","article-title":"Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a gynecologic oncology group study","volume":"47","author":"Sutton","year":"1993","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825804007747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825804007747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T18:01:04Z","timestamp":1548957664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825804007747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0090825804007747"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2004.09.028","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}